Profound Medical (PROF) Scheduled to Post Quarterly Earnings on Thursday

Profound Medical (NASDAQ:PROF) will release its earnings data after the market closes on Thursday, May 9th. Analysts expect Profound Medical to post earnings of ($0.31) per share for the quarter.

Profound Medical (NASDAQ:PROF) last posted its earnings results on Thursday, March 7th. The company reported ($0.42) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.28) by ($0.14). The company had revenue of $2.01 million for the quarter, compared to analysts’ expectations of $1.90 million. Profound Medical had a negative return on equity of 70.18% and a negative net margin of 396.85%. On average, analysts expect Profound Medical to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Profound Medical Stock Up 2.8 %

Profound Medical stock opened at $7.62 on Wednesday. The business has a fifty day moving average of $8.18 and a two-hundred day moving average of $8.68. The company has a quick ratio of 5.48, a current ratio of 6.58 and a debt-to-equity ratio of 0.16. The firm has a market cap of $186.16 million, a P/E ratio of -5.64 and a beta of 0.84. Profound Medical has a twelve month low of $7.11 and a twelve month high of $15.49.

About Profound Medical

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum.